Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Business Journal.
Press releases published on August 12, 2025
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
GlobeNewswire
·
August 12, 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with large B-cell …
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 12, 2025
Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial design elements. Company expects to begin enrolling …
H&R Block Reports Fiscal 2025 Results and Provides Fiscal 2026 Outlook
GlobeNewswire
·
August 12, 2025
- Delivered Revenue Growth of 4% and Earnings per Share Growth of 7% - - Returned $600 Million to Shareholders via Dividends and Share Repurchases - - Increases Quarterly Dividend by 12% - KANSAS CITY, Mo., Aug. 12, 2025 (GLOBE NEWSWIRE) -- H…
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 12, 2025
-- PIKture-01, a phase 1 clinical trial assessing OKI-219 in patients with advanced solid tumors, including breast cancer, is on track for single agent and fulvestrant combination data in Q4 2025 -- Initiated a new expansion arm of PIKture-01 to evaluate …
Varonis to Present at Upcoming Investor Conference
GlobeNewswire
·
August 12, 2025
MIAMI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its participation at the following upcoming conference: Citi's 2025 Global TMT Conference, September 2 – 5, in New York. The presentation …
DeFi Development Corp. Announces Second Quarter 2025 Earnings
GlobeNewswire
·
August 12, 2025
BOCA RATON, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- https://www.youtube.com/@DeFiDevCorp DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana …
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
- Positive IDMC Recommendation to Continue Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in AML Without Modification; Final Analysis Anticipated by Year-end 2025 – - Reported Positive Phase 2 Results of SLS009 in Relapsed/Refractory (r/r) Acute …
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 12, 2025
Randomized 3-month REMAIN-1 Midpoint Cohort data expected in September 2025 Positive 3-month REVEAL-1 Cohort data showed single Revita® procedure sustained weight loss after GLP-1 discontinuation; incremental 6-month open-label data expected in Q4 2025 Top …
NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
GlobeNewswire
·
August 12, 2025
-- Reported record quarterly revenue of $23.5 million in Q2 2025-- -- Increased full-year 2025 revenue guidance to between $94 million and $98 million and gross margin guidance to between 75% and 76%-- -- Remain on track to submit NAUTILUS data to FDA for …
Slide Reports Second Quarter 2025 Results
GlobeNewswire
·
August 12, 2025
- Gross Premiums Written Increased 25.0% Year-over-Year to $435.4 Million - - Net Income Grew 30.5% Year-over-Year to $70.1 Million; $0.56 Diluted Earnings Per Share - - Combined Ratio Improved 250 Basis Points Year-over-Year to 67.4% - - Completed Initial …
Alico, Inc. Announces Financial Results for the Third Quarter Ended June 30, 2025
GlobeNewswire
·
August 12, 2025
Company Completes Final Major Citrus Harvest as Strategic Transformation to Diversified Land Company Continues Company Reports $9.3 Million in Third Quarter Asset Sales; Exceeding its Land Sales Target Crop Insurance Recovery of $16.0 Million Contributes …
Iridex Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
MOUNTAIN VIEW, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Mobile Infrastructure Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
--Higher Contract Parking Volumes Reflect Positive Secular Growth Trends-- --Advancing Non-Core Asset Divestiture Strategy-- --Conference Call Will be Held Today at 4:30 PM ET-- CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mobile Infrastructure …
WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Delivered Revenue and Adjusted EBITDA above the top end of Guidance Ranges Second Quarter Revenue Growth of 8.5%; Revenue Growth on a Constant Currency Basis of 5.5% Net Loss of $3.9 Million; Adjusted EBITDA of $9.7 Million Strong Balance Sheet With Cash …
Inspirato Reports Q2 Financial and Operating Results
GlobeNewswire
·
August 12, 2025
DENVER, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results for the second quarter (“Q2 2025”) ended June 30, 2025. …
Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
Increased revenues by 157% to $1.8 million, compared with $0.7 million for the fiscal quarter ended June 30, 2024 Awarded a national group purchasing agreement for therapeutic gases by Premier, Inc., which has more than 4,350 member hospitals and health …
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and …
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
GlobeNewswire
·
August 12, 2025
Reported potentially best-in-class clinical efficacy and safety data from ongoing Phase 1b trial of ORIC-944 in combination with AR inhibitors for the treatment of patients with mCRPC Strengthened cash position with $244 million gross proceeds from top- …
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Presented three abstracts at American Society of Gene …
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T cell- …